Alanylation of teichoic acids protects Staphylococcus aureus against Toll-like receptor 2-dependent host defense in a mouse tissue cage infection model

Journal of Infectious Diseases

Volumn 188, Issue 3, 2003, Pages 414-423

  Kristian, Sascha A ^a,b,d   Lauth, Xavier ^c   Nizet, Victor ^c   Goetz, Friedrich ^a   Neumeister, Birgid ^b   Peschel, Andreas ^a   Landmann, Regine ^d  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE INFLAMMATORY PROTEIN 2; TEICHOIC ACID; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR;

ALANYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CAGE; CELL DEATH; CHEMICAL MODIFICATION; COLONY FORMING UNIT; HOST RESISTANCE; INFLAMMATION; LEUKOCYTE COUNT; MOUSE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIOCINS; DISEASE MODELS, ANIMAL; FEMALE; INFLAMMATION; LEUKOCYTE COUNT; LEUKOCYTES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOKINES; MUTATION; PEPTIDES; RECEPTORS, CELL SURFACE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TEICHOIC ACIDS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA; VIRULENCE;

EID: 0043159258     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/376533     Document Type: Article

References (44)

1. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339:520-32.
2. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284:1318-22.
3. Peschel A, Collins LV. Staphylococcal resistance to antimicrobial peptides of mammalian and bacterial origin. Peptides 2001; 22:1651-9.
4. Verhoef F. Host defense against infection. In: Crossley KB, Archer GL, eds. The staphylococci in human disease. New York: Churchill Livingstone, 1997:213-2.
5. Peschel A. How do bacteria resist human antimicrobial peptides? Trends Microbiol 2002; 10:179-86.
6. Yeaman MR, Bayer AS, Koo SP, Foss W, Sullam PM. Platelet microbicidal proteins and neutrophil defensin disrupt the Staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action. J Clin Invest 1998; 101:178-87.
7. Lehrer RI, Ganz T. Defensins of vertebrate animals. Curr Opin Immunol 2002; 14:96-102.
8. Gallo RL, Kim KJ, Bernfield M, et al. Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse. J Biol Chem 1997; 272:13088-93.
9. Harder J, Bartels J, Christophers E, Schroder JM. Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 2001; 276:5707-13.
10. Peschel A, Otto M, Jack RW, Kalbacher H, Jung G, Götz F. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity, to defensins, protegrins, and other antimicrobial peptides. J Biol Chem 1999; 274:8405-10.
11. Peschel A, Jack RW, Otto M, et al. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with L-lysine. J Exp Med 2001; 193:1067-76.
12. Collins V, Kristian SA, Weidenmaier C, et al. Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence-attenuated in mice. J Infect Dis 2002; 186:214-9.
13. Abachin E, Poyart C, Pellegrini E, et al. Formation of D-alanyl-lipoteichoic acid is required for adhesion and virulence of Listeria monocytogenes. Mol Microbiol 2002; 43:1-14.
14. Zimmerli W, Waldvogel FA, Vaudaux P, Nydegger UE. Pathogenesis of foreign body infection: description and characteristics of an animal model. J Infect Dis 1982; 146:487-97.
15. Zimmerli W. Tissue cage infection model. In: Zak O, Sande MA, eds. Handbook of animal models of infection. San Diego: Academic Press, 1999:409-17.
16. Vaudaux PPF, Lew DP, Waldvogel FA. Host factors predisposing to and influencing therapy of foreign body infections. In: Waldvogel FA, Bisno AL, eds. Infections associated with indwelling devices. Washington, DC: American Society for Microbiology Press, 2000:1-26.
17. Gross M, Cramton SE, Götz F, Peschel A. Key role of teichoic acid net charge in Staphylococcus aureus colonization of artificial surfaces. Infect Immun 2001; 69:3423-6.
18. Zimmerli W, Lew PD, Waldvogel FA. Pathogenesis of foreign body infection: evidence for a local granulocyte defect. J Clin Invest 1984; 73:1191-200.
19. Vaudaux P, Grau GE, Huggler E, et al. Contribution of tumor necrosis factor to host defense against staphylococci in a guinea pig model of foreign body infections. J Infect Dis 1992; 166:58-64.
20. Underhill DM, Ozinsky A. Toll-like receptors: key mediators of microbe detection. Curr Opin Immunol 2002; 14:103-10.
21. Beutler B. Toll-like receptors: how they work and what they do. Curr Opin Hematol 2002; 9:2-10.
22. Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 1999; 274:17406-9.
23. Opitz B, Schroder NW, Spreitzer I, et al. Toll-like receptor-2 mediates Treponema glycolipid and lipoteichoic acid-induced NF-κB translocation. J Biol Chem 2001; 276:22041-7.
24. Aliprantis AO, Yang RB, Mark MR, et al. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 1999; 285:736-9.
25. Birchler T, Seibl R, Buchner K, et al. Human Toll-like receptor 2 mediates induction of the antimicrobial peptide human β-defensin 2 in response to bacterial lipoprotein. Eur J Immunol 2001; 31:3131-7.
26. Takeuchi O, Hoshino K, Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 2000; 165:5392-6.
27. Echchannaoui H, Frei K, Schnell C, Leib S, Zimmerli W, Landmann R. Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis due to reduced bacterial clearing and enhanced inflammation. J Infect Dis 2002; 186:798-806.
28. Iordanescu S, Surdeanu M. Two restriction and modification systems in Staphylococcus aureus NCTC8325. J Gen Microbiol 1976; 96:277-81.
29. Dayer E, Yoshida H, Izui S, Lambert PH. Quantitation of retroviral gp70 antigen, autoantibodies, and immune complexes in extravascular space in arthritic MRL-lpr/lpr mice: use of a subcutaneously implanted tissue cage model. Arthritis Rheum 1987; 30:1274-82.
30. Dawson J, Rordorf-Adam C, Geiger T, et al. Interleukin-1 (IL-1) production in a mouse tissue chamber model of inflammation. I. Development and initial characterisation of the model. Agents Actions 1993; 38:247-54.
31. Zimmerli W, Frei R, Widmer AF, Rajacic Z. Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. J Antimicrob Chemother 1994; 33:959-67.
32. Cauwels A, Frei K, Sansano S, et al. The origin and function of soluble CD14 in experimental bacterial meningitis. J Immunol 1999; 162:4762-72.
33. Nizet V, Ohtake T, Lauth X, et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 2001; 414:454-7.
34. Zimmerli W, Zak O, Vosbeck K. Experimental hematogenous infection of subcutaneously implanted foreign bodies. Scand J Infect Dis 1985; 17:303-10.
35. Gresham HD, Lowrance JH, Caver TE, Wilson BS, Cheung AL, Lindberg FP. Survival of Staphylococcus aureus inside neutrophils contributes to infection. J Immunol 2000; 164:3713-22.
36. Underhill DM, Ozinsky A. Phagocytosis of microbes: complexity in action. Annu Rev Immunol 2002; 20:825-52.
37. Tsujimoto H, Ono S, Mochizuki H, et al. Role of macrophage inflammatory protein 2 in acute lung injury in murine peritonitis. J Surg Res 2002; 103:61-7.
38. Walev I, Weller U, Strauch S, Foster T, Bhakdi S. Selective killing of human monocytes and cytokine release provoked by sphingomyelinase (β-toxin) of Staphylococcus aureus. Infect Immun 1996; 64:2974-9.
39. 2 against Staphylococcus aureus. J Biol Chem 2002; 277:47636-44.
40. Lien E, Sellati TJ, Yoshimura A, et al. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem 1999; 274:33419-25.
41. 2 gene in inbred mouse strains. J Biol Chem 1995; 270:22378-85.
42. Christen S, Schaper M, Lykkesfeldt J, et al. Oxidative stress in brain during experimental bacterial meningitis: differential effects of α-phenyl-tert-butyl nitrone and N-acetylcysteine treatment. Free Radic Biol Med 2001; 31:754-62.
43. Underhill DM, Ozinsky A, Smith KD, Aderem A. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc Natl Acad Sci USA 1999; 96:14459-63.
44. Thoma-Uszynski S, Stenger S, Takeuchi O, et al. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 2001; 291:1544-7.